Home / News / SHL Medical / SHL to participate in Prefilled Syringe Seminar 2018 Tokyo
Events| April 01, 2018

SHL to participate in Prefilled Syringe Seminar 2018 Tokyo

Press Release 201804 Pda Japan 2018

SHL Group is looking forward to exhibiting at the Prefilled Syringe Seminar 2018 Tokyo held by the Parenteral Drug Association (PDA) Japan Chapter from May 22-23.

The annual seminar will bring together global pharma and medical device experts in an exploration of this year’s theme: the best solution for the patient from the viewpoint of drugs, containers, and devices.

SHL Group will join the event with a showcase of its advanced drug delivery solutions, which include innovative offerings for high volume/high viscosity formulations designed to meet the needs of next-generation therapies.

For the first time in Japan, SHL will be demonstrating Maggie®, a high-volume cartridge-based autoinjector built with the market-proven Needle Isolation Technology (NIT®). SHL will also present its high-volume Molly® 2.25, which offers a shorter development timeline for faster commercialization, and Rotaject®, a state-of-the-art constant force technology that safely delivers viscosities up to several hundred centipoise within seconds.

SHL is pleased to bring its latest portfolio to Japan, a leading market in Asia for self-administered injection devices, and to help biotech and pharma players from around the world to meet their clinical and commercialization needs.

To find out more about SHL’s autoinjection devices and digital solutions, stop by the Sola City Conference Center in Tokyo, Japan from May 22-23.

About SHL Medical

As a world-leading solutions provider of advanced drug delivery systems, SHL Medical is the partner of choice for many leading pharma and biotech companies. Driven by our company purpose – Enabling Patients’ Independence – we offer patient-centric solutions for the design, development, and manufacturing of autoinjectors, pen injectors, as well as innovative specialty delivery systems for large-volume and high-viscosity formulations. We also offer final assembly, labeling, and packaging solutions for our drug delivery systems.  ​

In response to the rising trend in home therapy, SHL has increased developmental work in the digital healthcare sector to help improve the drug delivery ecosystem. ​

Located across Switzerland, Taiwan, Sweden, and the US, our global team of experts collaborate seamlessly as one team in utilizing our comprehensive in-house manufacturing capabilities. Our solutions offer customization and optimization for each project while proactively weaving sustainability-driven measures into our designs and processes to contribute to a cleaner earth.​

For additional information, visit www.shl-medical.com

Media contact: info@shl-medical.com

Share:

Related News